Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone


Here's Why Teva Pharmaceutical Industries Ltd (ADR) Is Sinking Like a Stone

In response to reporting rough second-quarter results, shares of Teva Pharmaceutical Industries (NYSE: TEVA), a leading provider of generic drugs, dropped 24% as of 1:15 p.m. EDT on Thursday.

Here's a review of the key takeaways from the company's second-quarter results:

The lower-than-hoped for results also caused management to pull back on its guidance for the year. The company now expects adjusted full-year revenue to land between $22.8 billion and $23.2 billion. That's down from its prior outlook of $23.8 billion to $24.5 billion.

Continue reading


Source: Fool.com

Like: 0
AGN
Teilen

Kommentare